Regenerative medicine, the most recent and emerging branch of medical science, deals
with functional restoration of tissues or organs for the patient suffering from severe injuries or …

Advances in single-cell technology and genetic mouse models have resulted in the
identification of new types of hemopoietic stem cells (HSC), resulting in baffling …

Haploidentical stem cell transplantation (haploSCT) has advanced to a common procedure
for treating patients with hematological malignancies and immunodeficiency diseases …

In the coming era of precision medicine, there is a high demand for the development of
approaches for in vivo tracking of biomolecules and measurements of their local …

In patients with AML with FMS‐like tyrosine kinase 3 (FLT3) mutations, the significance of
minimal residual disease (MRD) detected by PCR before allogeneic stem cell …

Background Peripheral-blood (PB) and bone marrow (BM) are both widely used in
hematopoietic stem cell transplantation (HSCT). However, it is unclear whether PB or BM …

Background Outcomes of haploidentical hematopoietic cell transplantation (haplo-HCT) with
post-transplant cyclophosphamide (PT-Cy) have greatly improved. It remains unknown …

Background: Deteriorations in tissues and decline in organ functions, due to chronic
diseases or with advancing age or sometimes due to infections or injuries, can severely …

We compared the safety and efficacy of haploidentical stem cell transplantation (haplo-SCT)
to matched donor SCT (matched-SCT) in treating hematological malignancies. The Medline …

HLA-haploidentical hematopoietic stem cell transplantation (HSCT) may be an option for
severe aplastic anemia (SAA) patients. However, to date, no large-sample studies have …